Effectiveness of Upadacitinib Versus Other Advanced Therapies in Rheumatoid Arthritis After Tumor Necrosis Factor Inhibitor Use in the United States

Charles-Schoeman C, Oelke K, Saffore CD, Kadakia A, Peng Y, Fang S, Markley G, Bergman MJ. Effectiveness of Upadacitinib Versus Other Advanced Therapies in Rheumatoid Arthritis After Tumor Necrosis Factor Inhibitor Use in the United States. Rheumatol Ther. 2026 Nov 3. doi: 10.1007/s40744-026-00885-8. Epub ahead of print. PMID: 42975613.


Related Posts